Ticker | Company | Zen Score | Valuation Score | Financials Score | Forecast Score | Performance Score | Dividends Score |
---|---|---|---|---|---|---|---|
CCRN | CROSS COUNTRY HEALTHCARE INC | 70 | 100 | 86 | 44 | 50 | – |
CORT | CORCEPT THERAPEUTICS INC | 67 | 71 | 71 | 56 | 70 | – |
KMDA | KAMADA LTD | 65 | 86 | 86 | 67 | 20 | – |
INCY | INCYTE CORP | 64 | 86 | 86 | 56 | 30 | – |
NBIX | NEUROCRINE BIOSCIENCES INC | 64 | 43 | 86 | 67 | 60 | – |
Upgrade to Premium to View MoreUse Zen Score to quickly analyze stock fundamentals, even if you don't have a finance background. We run time-tested due diligence checks inspired by legendary investors like Warren Buffett, and score each company based on how many they pass/fail. Already have a premium account? Sign In |
Industry | Stocks | 1d % | 1w % | 1m % | 1y % | Zen Score | P/E ratio | P/B Ratio | ROE | ROA | ROCE | Upside/Downside | Consensus |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
679 | -0.70% | +1.84% | +3.96% | -19.69% | 8.47x | 6.01x | +18.62% | +3.83% | -27.52% | +77.73% | Strong Buy | ||
64 | -0.44% | +1.56% | +12.99% | +11.25% | 38.96x | 4.47x | -13.18% | +6.48% | +11.49% | +5.02% | Buy | ||
18 | -0.03% | +1.66% | +7.51% | +18.11% | 31.85x | 6.42x | +33.60% | +8.10% | +14.22% | +11.01% | Buy | ||
87 | -0.75% | +1.10% | +5.60% | -1.99% | -1.01x | 2.20x | +12.36% | +3.36% | +6.05% | +32.29% | Strong Buy | ||
12 | +0.52% | +1.22% | +4.66% | +4.46% | 25.53x | 3.07x | +15.18% | +4.74% | +11.78% | +11.78% | Buy | ||
61 | +0.25% | +2.04% | -0.03% | -19.66% | 9.15x | 3.33x | +6.71% | +2.23% | +5.33% | +26.88% | Buy | ||
51 | -0.09% | +0.01% | +4.96% | +11.10% | 39.23x | 4.59x | -92.23% | +6.58% | +13.66% | +15.22% | Buy | ||
150 | -0.35% | +1.37% | +2.08% | -13.46% | 30.60x | 4.00x | +7.35% | +5.26% | +8.26% | +19.86% | Buy | ||
10 | +0.87% | +0.34% | +1.16% | +26.37% | 26.84x | 107.17x | -11.87% | +3.44% | +19.58% | +10.98% | Buy | ||
56 | +0.16% | +1.85% | +6.62% | -5.76% | 59.83x | 3.64x | +11.25% | +7.73% | +10.05% | +18.23% | Buy |